
VIR vs NVAX
$VIR vs $NVAX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
VIR vs NVAX: the quick read
- ·VIR is the larger company by market cap ($1.89B vs $1.73B).
- ·NVAX has been more active on our scanner (160 vs 63 alerts in 30 days).
- ·NVAX has the smaller float (150.2M vs 151.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 160 and 63 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 10% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing VIR and NVAX on TheDesperateTrader.
- Is VIR or NVAX the better stock?
- "Better" depends on your goal, and these two are not alike. VIR is the larger company by market cap ($1.89B vs $1.73B). NVAX has been more active on our scanner (160 vs 63 alerts in 30 days). NVAX has the smaller float (150.2M vs 151.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between VIR and NVAX?
- The differences that matter: they are not in the same business - VIR is biological products, (no diagnostic substances) and NVAX is biological products, (no diagnostic substances); they are similar in size ($1.89B vs $1.73B); they trade at very different share prices ($11.17 vs $10.49); VIR sits at 89% of its 52-week range against 74% for NVAX; our scanner flagged VIR 63 times in the last 30 days against 160 for NVAX. Everything above is measured from the latest completed session and SEC filings.
- Which of VIR and NVAX is more active right now?
- Right now VIR is at about 1.1x its normal volume and NVAX is at about 0.7x, so VIR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading VIR or NVAX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore VIR and NVAX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.